6/1/2007

Trial Examines Optimal Treatments for HER2-Positive Early Breast Cancer

Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage breast cancer after surgery and chemotherapy. Read more ...

10/1/2006

Trial Examines Value of Circulating Cancer Cells in Advanced Cancer

Trial studies whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not Read more ...

8/1/2006

Sexual Well-Being and Breast Cancer Study for Women who Partner with Women

Boston University researchers seek lesbians, bisexual women and women who partner with women who have or have not had breast cancer to complete a survey about sexual well-being Read more ...

7/1/2006

Study on Lapatinib Launched for HER2/neu Positive, Early-Stage Disease

If you have HER2/neu positive, early-stage cancer and did not take Herceptin, you may be eligible to participate in this trial studying the effectiveness of lapatinib in preventing a recurrence of your breast cancer. Read more ...

3/24/2006

TAILORx Trial Seeks Targeted Treatments for ER+, Node Negative Breast Cancers

Trial compares hormonal therapy alone vs hormonal therapy and chemotherapy for ER+, node negative breast cancer. Read more ...

2/1/2006

Bevacizumab Subject of Research Study for People With Previously Treated Advanced Breast Cancer

Bevacizumab and chemotherapy will be compared to chemotherapy alone for people with previously treated advanced breast cancer in a new national clinical trial. Read more ...

12/9/2005

Study Compares Effectiveness of Aromatase Inhibitors Given Before Surgery

If you are postmenopausal and have ER+ cancer, you may be eligible for a trial studying aromatase inhibitor use before surgery Read more ...

12/1/2005

Researchers Study Bevacizumab as a First-Line Treatment for People with Advanced Breast Cancer

Bevacizumab and chemotherapy will be compared to chemotherapy alone as first-line therapy for people with advanced breast cancer in a national clinical trial. Read more ...

7/23/2005

Research Study Looks at Bisphosphonates for Early-Stage Breast Cancer

A study looks at whether bisphosphonates may be used to prevent bone metastasis in women with early breast cancer at high risk for recurrence. Read more ...

4/1/2005

New Trial Determines Effectiveness, Safety of New Treatment for Women with Inflammatory Breast Cance

A study for women newly diagnosed with inflammatory breast cancer will examine the safety and efficacy of a new targeted therapy, lapatinib, in combination with paclitaxel. Read more ...

6/23/2004

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

If you were recently diagnosed with lymph node-negative breast cancer, you may be eligible for a clinical trial comparing two combination chemotherapy treatments. Read more ...

7/26/2003

Clinical Trial for Pre-Menopausal Women Compares Hormonal Treatments

A randomized phase III clinical trial will compare triptoreline (brand name: Trelstar Depot) and tamoxifen (brand name: Nolvadex) versus triptoreline and exemestane (brand name: Aromasin) in women whose cancers grow in the presence of hormones. Read more ...

Ongoing

Trial for Young Women Studies Ovarian Function Suppression Combined with Hormone Therapy

A randomized phase III trial for young women who have undergone surgery for hormone-responsive breast cancer will compare ovarian function suppression and tamoxifen (brand name: Nolvadex) versus ovarian function suppression and exemestane (brand name: Aromastin) versus tamoxifen alone Read more ...

Ongoing

Phase III Trial for Pre-Menopausal Women With Hormone Receptor Positive Breast Cancer

A phase III clinical trial for premenopausal women with hormone receptor positive breast cancer examines the benefits of ovarian function suppression, tamoxifen or exemestane with, versus without, adjuvant chemotherapy URL text: Read more about this clinical trial. Read more ...

Ongoing

Trial for Young Women Studies Effectiveness of Goserelin to Prevent Early Menopause

A randomized phase III clinical trial for young women with stage I-IIIA hormone receptor-negative breast cancer compares the effectiveness of ovarian suppression using goserelin combined with chemotherapy versus chemotherapy alone in preventing early menopause. Read more ...

Ongoing

Fulvestrant Possible as First-Line Treatment for Advanced Breast Cancer

Trial compares anastrozole alone to combination of anastrozole, fulvestrant in ER+ metastatic breast cancer. Read more ...

Ongoing

New Trial Compares Chemotherapy Regimens for Women with Advanced Breast Cancer

If you are living with metastatic disease, you may qualify for a clinical trial comparing a combination chemotherapy regimen to a single-agent treatment Read more ...

Ongoing

New Trial Compares Partial Breast Irradiation to Whole Breast Radiation Therapy

The effectiveness of different radiation therapy techniques will be examined in a trial for women with early-stage breast cancer. Read more ...